Masimo Corp. Stock
Masimo Corp. Stock
Pros and Cons of Masimo Corp. in the next few years
Pros
Cons
Performance of Masimo Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Masimo Corp. | 0.360% | 1.687% | 35.105% | 0.853% | 38.264% | -7.602% | -21.954% |
| Neogen Corp. | -3.070% | -4.762% | -11.602% | -4.192% | 30.081% | - | - |
| CONMED Corp. | 1.890% | -6.358% | -7.429% | -39.439% | -7.429% | -62.543% | -68.846% |
| Bio-Techne Corp. | 1.790% | -10.442% | -18.165% | -19.640% | -10.800% | -35.362% | - |
Comments
News
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement
On February 17, 2026, Parkman Healthcare Partners disclosed a new position in Masimo Corporation (NASDAQ:MASI), acquiring 200,000 shares in the fourth quarter worth an estimated $26.01 million at
Naya Capital Adds Masimo Shares
According to an SEC filing dated Feb. 18, Naya Capital Management UK Ltd disclosed a new position in Masimo (NASDAQ:MASI), acquiring nearly 1.6 million shares.
Masimo is a leading provider of
4D Advisors Offloads $7.6 Million in Masimo (MASI) Stock, Selling 45,000 Shares
On Nov. 14, 2025, 4D Advisors, LLC disclosed in a regulatory filing that it sold out its entire position in Masimo (NASDAQ:MASI). The sale was valued at $7.57 million.
According to a filing with the


